Kwang Dong Pharmaceutical Co., Ltd. (KOSE:A009290) announces a share repurchase program. Under the program, the company will repurchase its shares up to 1,000,000. The purpose of the plan is to stabilize stock price and enhance shareholders value.

The plan will be valid till July 11, 2023. As of April 10, 2023, the company had 11,340,239 shares in treasury within scope available for dividend and had 0 shares in treasury through other repurchase.